Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$33.11 - $55.01 $77,676 - $129,053
-2,346 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$50.07 - $66.05 $68,946 - $90,950
-1,377 Reduced 36.99%
2,346 $117,000
Q2 2021

Aug 06, 2021

SELL
$56.61 - $80.46 $31,475 - $44,735
-556 Reduced 12.99%
3,723 $235,000
Q1 2021

May 03, 2021

BUY
$86.23 - $125.19 $368,978 - $535,688
4,279 New
4,279 $398,000
Q4 2020

Feb 04, 2021

SELL
$79.17 - $111.47 $23,751 - $33,441
-300 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$81.91 - $134.94 $24,573 - $40,482
300 New
300 $31,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $522M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.